.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Moodys
Medtronic
Novartis
Express Scripts
Healthtrust
Boehringer Ingelheim
Queensland Health
QuintilesIMS

Generated: November 23, 2017

DrugPatentWatch Database Preview

Famotidine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for famotidine and what is the scope of famotidine patent protection?

Famotidine
is the generic ingredient in eleven branded drugs marketed by Perrigo, J And J Consumer Inc, Sandoz, Mylan, Watson Labs, Hospira, Carlsbad, Apothecon, Fresenius Kabi Usa, Merck, Apotex, Ivax Sub Teva Pharms, Teva, Ucb Inc, Alembic Pharms Ltd, Dr Reddys Labs Ltd, Navinta Llc, Athenex Inc, Apotex Inc, Salix Pharms, Abbvie, Aurobindo Pharma Ltd, Wockhardt, Sun Pharm Inds, Lupin Ltd, Mylan Labs Ltd, Merck Sharp Dohme, Actavis Elizabeth, Perrigo R And D, Mylan Pharms Inc, Valeant Pharms North, Sun Pharm Inds Ltd, West-ward Pharms Int, Baxter Hlthcare, Hi-tech Pharma Co, Novel Labs Inc, and Horizon Pharma, and is included in sixty-nine NDAs. There are nine patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Famotidine has sixteen patent family members in nine countries.

There are eighteen drug master file entries for famotidine. One hundred and twenty-three suppliers are listed for this compound. There are five tentative approvals for this compound.

Pharmacology for famotidine

Medical Subject Heading (MeSH) Categories for famotidine

Tentative approvals for FAMOTIDINE

Applicant Application No. Strength Dosage Form
u► Subscribe10MG/MLInjectable; Injection
u► Subscribe10MG/MLInjectable; Injection
u► Subscribe10MG/MLInjectable; Injection
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Athenex Inc
FAMOTIDINE
famotidine
INJECTABLE;INJECTION075684-001Apr 16, 2001APRXNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
FAMOTIDINE
famotidine
INJECTABLE;INJECTION075488-001Apr 16, 2001APRXNoYes► Subscribe► Subscribe► Subscribe
Valeant Pharms North
PEPCID
famotidine
TABLET;ORAL019462-002Oct 15, 1986ABRXYesYes► Subscribe► Subscribe► Subscribe
Hospira
FAMOTIDINE
famotidine
INJECTABLE;INJECTION075705-001Apr 16, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020325-001Apr 28, 1995OTCYesNo► Subscribe► Subscribe► Subscribe
Alembic Pharms Ltd
FAMOTIDINE
famotidine
TABLET;ORAL078916-002May 22, 2009ABRXNoNo► Subscribe► Subscribe► Subscribe
Merck
PEPCID RPD
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL020752-002May 28, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharms North
PEPCID
famotidine
TABLET;ORAL019462-001Oct 15, 1986ABRXYesNo► Subscribe► Subscribe► Subscribe
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
Horizon Pharma
DUEXIS
famotidine; ibuprofen
TABLET;ORAL022519-001Apr 23, 2011RXYesYes► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: famotidine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck Sharp Dohme
PEPCID PRESERVATIVE FREE IN PLASTIC CONTAINER
famotidine
INJECTABLE;INJECTION020249-001Feb 18, 1994► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020325-001Apr 28, 1995► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020325-001Apr 28, 1995► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET, CHEWABLE;ORAL020801-001Sep 24, 1998► Subscribe► Subscribe
Merck
PEPCID RPD
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL020752-002May 28, 1998► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET, CHEWABLE;ORAL020801-001Sep 24, 1998► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET, CHEWABLE;ORAL020801-002Dec 17, 2007► Subscribe► Subscribe
Merck
PEPCID RPD
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL020752-001May 28, 1998► Subscribe► Subscribe
Merck
PEPCID RPD
famotidine
TABLET, ORALLY DISINTEGRATING;ORAL020752-002May 28, 1998► Subscribe► Subscribe
J And J Consumer Inc
PEPCID AC
famotidine
TABLET;ORAL020902-001Aug 5, 1999► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: famotidine

Country Document Number Estimated Expiration
Australia726336► Subscribe
Hong Kong1137654► Subscribe
Canada2284663► Subscribe
European Patent Office2147669► Subscribe
Denmark2147669► Subscribe
European Patent Office2266538► Subscribe
Japan5072513► Subscribe
Australia6896998► Subscribe
Japan2012162558► Subscribe
European Patent Office0975336► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Fish and Richardson
Farmers Insurance
Colorcon
Chubb
Cerilliant
Johnson and Johnson
Daiichi Sankyo
Fuji
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot